About
Care and conscience are
the core of our corporate values
more
the core of our corporate values
21 Mar,2022
Zylox-Tonbridge: Approval for Commercialization of Multiple Products Enabled 544% Year-on-year Revenue Growth for the Company in 2021
Zylox-Tonbridge (2190.HK, hereinafter called the Company) announced on March 15 its first fiscal-year financial report since its IPO on Hong Kong Stock Exchange.The Company reported an ope...
more
02 Mar,2022
Approval Granted for Full Circulation of Zylox-Tonbridge H shares, Significantly Raising its Circulation Market Capitalization
Zylox-Tonbridge Medical Technology Co., Ltd. ("Zylox-Tonbridge" or "the Company", "2190.HK") announced on February 28 that it has received approval from Hong Kong Stock E...
more
25 Jan,2022
Zylox-Tonbridge's strategic investment in Wire Sciences boosts the development of innovative vascular intervention surgical robots
On January 17, Zylox-Tonbridge (2190.HK, “the Company”) announced the completion of its strategic investment in Wire Sciences Medical Technology（Suzhou）Co., Ltd. (“Wire Sciences”). By leveraging its own s...
more
27 Dec,2021
ZYLOX-TONBRIDGE Postdoctoral Workstation was Officially Inaugurated to Help Cultivate High-level Talents in the Medical Device Industry
On December 13, Zylox-Tonbridge's postdoctoral workstation in cooperation with Zhejiang University (hereinafter referred to as "postdoctoral workstation”) was officially inaugurated.On the s...
more
30 Nov,2021
ZYLOX-TONBRIDGE Completed Patient Enrollment for Its Flow Diverter Clinical Trial in Less Than Five Months
Hangzhou, China, 29 November 2021- Zylox-Tonbridge (2190.HK, the “Company”) announced the last patient enrollment was completed for the clinical trial of “Tonbridge KylinTM” Flow Diverter (single ...
more
30 Nov,2021
ZYLOX-TONBRIDGE Holds First Investor Day Event to Explore Development Opportunities for Domestic Substitution
On November 16, 2021, Zylox-Tonbridge (2190.HK) successfully held the first Investor Day Event at its Hangzhou Headquarter. The event brought together more than 100 institutional investors and securit...
more
